Immediate Impact
55 standout
Citing Papers
Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy
2023 Standout
Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses
2023 Standout
Works of Joel Wallace being referenced
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Joel Wallace | 245 | 103 | 150 | 137 | 17 | 777 | |
| Sang Mee Lee | 115 | 73 | 240 | 71 | 49 | 842 | |
| Joaquim Fernandes | 335 | 22 | 122 | 49 | 17 | 888 | |
| Hazel Squires | 220 | 113 | 182 | 51 | 51 | 947 | |
| Ayden Tajahmady | 79 | 106 | 87 | 39 | 14 | 763 | |
| Lih‐Wen Mau | 104 | 27 | 145 | 113 | 45 | 678 | |
| Mark Minchin | 346 | 77 | 191 | 35 | 8 | 832 | |
| Ruixuan Jiang | 258 | 59 | 120 | 47 | 37 | 784 | |
| Vinit Nair | 180 | 40 | 103 | 33 | 32 | 871 | |
| Edwin D. Huff | 236 | 85 | 286 | 76 | 15 | 785 | |
| Kathleen Lang | 159 | 153 | 83 | 77 | 33 | 747 |
All Works
Loading papers...